AMAN (ALLIANCE OF NUSANTARA INDIGENOUS PEOPLE) PUBLIC RELATIONS COMMUNICATION IN THE COVID-19 VACCINE PRIORITY PROGRAM

Abstract

Public relations in practice has a relationship with the science of communication because both are a unifed whole and a link that supports public relations activities. Public relations itself cannot be separated from the composition of strategies that serve as guidelines or guidelines for acting which contain program formulations towards the goals that have been determined. The strategy itself does not only exist in the realm of public relations or the organization in general. This study aims to determine the Public Relations Communication of the Alliance of Nusantara Indigenous People (AMAN) in the priority vaccine program for indigenous peoples so that the fulfllment of the Covid-19 vaccine for Indigenous peoples is achieved without getting opposition from the public and achieving this goal. The research method uses a qualitative case study research design, where the case study is a comprehensive description and explanation of several aspects of a group or an organization. The data are collected through on-site data collection through in-depth observations and interviews with informants. The results of this study are to determine the success of Public Relations communication carried out by AMAN (Alliance of Nusantara Indigenous People) in the participation of indigenous peoples in the Covid-19 vaccine priority program. Public Relations itself is a planned communication both into and out between an organization and all its audiences in order to achieve the goals of an organization. Public Relations strategy must consider the right way to be able to integrate the most practical way. Public Relations activities carried out by the Alliance of Nusantara Indigenous People in the priority vaccine program consisting of 4 (four) strategies: (1) Analysis of the number of indigenous peoples who have not received the priority vaccine program, (2) Planning the Covid-19 vaccine priority work program, (3) Work program, and (4) Evaluation of priority vaccine programs.